What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.
about
A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma.Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy.Comparing the efficacy of induction-concurrent with concurrent-adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis.Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study.The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United Kingdom.Resolve conflicting rankings of outcomes in network meta-analysis: Partial ordering of treatments.SEOM clinical guideline in nasopharynx cancer (2017).Head and neck cancer in Hong Kong.A Network Meta-analysis Comparing the Efficacy and Safety of Anti-PD-1 with Anti-PD-L1 in Non-small Cell Lung Cancer.Prospective evaluation of plasma Epstein-Barr virus DNA clearance and fluorodeoxyglucose positron emission scan in assessing early response to chemotherapy in patients with advanced or recurrent nasopharyngeal carcinoma.Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy.Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.Assessment of Concurrent Chemoradiotherapy plus Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma: Cisplatin, Fluorouracil, and Docetaxel versus Gemcitabine and Cisplatin
P2860
Q38702239-C3414AB4-67A4-4C4C-9327-DAF11E096306Q40078689-CCB7B129-F78F-487A-9AE9-A94804268ED8Q41695908-9A4EEAFE-04C8-473A-84CC-E8A8A66F90DDQ45814922-28EE0164-EB3B-47E5-8B9E-89A24B398DC1Q46721131-F5B3293F-0185-4DCB-B896-AEC577A49A28Q47122053-1D3E256D-D6B5-4771-8940-2BF2E3D93EA2Q48185045-5CFDF9B2-2C8D-4AAF-A5B5-C569CCB47A13Q48236677-7706FC46-7BE4-45CC-A29C-69E6D15FB58FQ48370700-32F6131B-BE7E-41F0-8FBE-E47DE5E3A6FAQ49960053-5DCFB839-18B5-412F-B6A2-78671AA59803Q52576046-DC7BCA4B-E31B-437F-9CF8-7B48F3E97D55Q52647899-666FF937-60ED-41B9-AE4E-943918847D5FQ54252946-363F6C2A-519E-4EE2-B56D-2A12CB39D265Q54594897-70A2E8FE-95CB-44E1-90B5-633CCBDBB34CQ57805795-214A1F83-36C0-4AE8-9C21-0A230F6CDF5F
P2860
What Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.
description
2016 nî lūn-bûn
@nan
2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
What Is the Best Treatment of ...... nt Data Network Meta-Analysis.
@ast
What Is the Best Treatment of ...... nt Data Network Meta-Analysis.
@en
type
label
What Is the Best Treatment of ...... nt Data Network Meta-Analysis.
@ast
What Is the Best Treatment of ...... nt Data Network Meta-Analysis.
@en
prefLabel
What Is the Best Treatment of ...... nt Data Network Meta-Analysis.
@ast
What Is the Best Treatment of ...... nt Data Network Meta-Analysis.
@en
P2093
P2860
P50
P356
P1476
What Is the Best Treatment of ...... ent Data Network Meta-Analysis
@en
P2093
Anne W M Lee
Daniel T T Chua
Dora L W Kwong
George Fountzilas
Guopei Zhu
Hai-Qiang Mai
James Moon
Jean Bourhis
Kwan-Hwa Chi
P2860
P304
P356
10.1200/JCO.2016.67.4119
P407
P577
2016-12-05T00:00:00Z